nodes	percent_of_prediction	percent_of_DWPC	metapath
Selegiline—CYP2D6—breast cancer	0.0788	0.389	CbGaD
Selegiline—L-Phenylalanine—Melphalan—breast cancer	0.0741	0.405	CrCrCtD
Selegiline—CYP3A4—breast cancer	0.0676	0.334	CbGaD
Selegiline—Benzphetamine—Toremifene—breast cancer	0.0668	0.365	CrCrCtD
Selegiline—ABCB1—breast cancer	0.0563	0.278	CbGaD
Selegiline—Benzphetamine—Tamoxifen—breast cancer	0.0419	0.229	CrCrCtD
Selegiline—CYP2A6—Letrozole—breast cancer	0.0404	0.104	CbGbCtD
Selegiline—CYP2B6—Thiotepa—breast cancer	0.0178	0.0458	CbGbCtD
Selegiline—CYP1A2—Anastrozole—breast cancer	0.0138	0.0355	CbGbCtD
Selegiline—CYP1A2—Toremifene—breast cancer	0.0126	0.0324	CbGbCtD
Selegiline—CYP2C9—Anastrozole—breast cancer	0.0124	0.032	CbGbCtD
Selegiline—CYP2A6—Tamoxifen—breast cancer	0.012	0.031	CbGbCtD
Selegiline—CYP2B6—Raloxifene—breast cancer	0.0119	0.0306	CbGbCtD
Selegiline—CYP2C8—Lapatinib—breast cancer	0.0119	0.0306	CbGbCtD
Selegiline—ABCB1—Toremifene—breast cancer	0.011	0.0284	CbGbCtD
Selegiline—CYP2C19—Lapatinib—breast cancer	0.00995	0.0256	CbGbCtD
Selegiline—CYP3A4—Exemestane—breast cancer	0.00951	0.0245	CbGbCtD
Selegiline—CYP2C9—Idarubicin—breast cancer	0.00939	0.0242	CbGbCtD
Selegiline—CYP2C8—Raloxifene—breast cancer	0.00898	0.0232	CbGbCtD
Selegiline—CYP2A6—Fluorouracil—breast cancer	0.00887	0.0229	CbGbCtD
Selegiline—CYP2D6—Idarubicin—breast cancer	0.00859	0.0221	CbGbCtD
Selegiline—CYP3A4—Letrozole—breast cancer	0.00808	0.0208	CbGbCtD
Selegiline—ABCB1—Lapatinib—breast cancer	0.00802	0.0207	CbGbCtD
Selegiline—CYP2E1—Tamoxifen—breast cancer	0.00795	0.0205	CbGbCtD
Selegiline—CYP2B6—Tamoxifen—breast cancer	0.00784	0.0202	CbGbCtD
Selegiline—CYP2E1—Mitoxantrone—breast cancer	0.00775	0.02	CbGbCtD
Selegiline—CYP3A4—Anastrozole—breast cancer	0.00721	0.0186	CbGbCtD
Selegiline—CYP3A4—Toremifene—breast cancer	0.00659	0.017	CbGbCtD
Selegiline—CYP3A4—Fulvestrant—breast cancer	0.00613	0.0158	CbGbCtD
Selegiline—CYP2B6—Irinotecan—breast cancer	0.00602	0.0155	CbGbCtD
Selegiline—CYP2C8—Tamoxifen—breast cancer	0.00594	0.0153	CbGbCtD
Selegiline—CYP3A4—Thiotepa—breast cancer	0.00546	0.0141	CbGbCtD
Selegiline—CYP2C9—Capecitabine—breast cancer	0.00515	0.0133	CbGbCtD
Selegiline—CYP3A4—Ixabepilone—breast cancer	0.00499	0.0129	CbGbCtD
Selegiline—CYP2C19—Tamoxifen—breast cancer	0.00498	0.0128	CbGbCtD
Selegiline—CYP3A4—Lapatinib—breast cancer	0.00481	0.0124	CbGbCtD
Selegiline—CYP2C8—Paclitaxel—breast cancer	0.00462	0.0119	CbGbCtD
Selegiline—CYP1A2—Tamoxifen—breast cancer	0.0046	0.0118	CbGbCtD
Selegiline—ABCB1—Vinorelbine—breast cancer	0.00445	0.0115	CbGbCtD
Selegiline—CYP2C8—Fluorouracil—breast cancer	0.00437	0.0113	CbGbCtD
Selegiline—CYP2D6—Vinorelbine—breast cancer	0.00419	0.0108	CbGbCtD
Selegiline—CYP2C9—Tamoxifen—breast cancer	0.00414	0.0107	CbGbCtD
Selegiline—ABCB1—Tamoxifen—breast cancer	0.00402	0.0104	CbGbCtD
Selegiline—ABCB1—Mitoxantrone—breast cancer	0.00392	0.0101	CbGbCtD
Selegiline—CYP2D6—Tamoxifen—breast cancer	0.00379	0.00976	CbGbCtD
Selegiline—CYP3A4—Raloxifene—breast cancer	0.00364	0.00939	CbGbCtD
Selegiline—ABCB1—Gemcitabine—breast cancer	0.00346	0.00892	CbGbCtD
Selegiline—CYP1A2—Fluorouracil—breast cancer	0.00339	0.00873	CbGbCtD
Selegiline—CYP2B6—Doxorubicin—breast cancer	0.00329	0.00848	CbGbCtD
Selegiline—CYP2C9—Paclitaxel—breast cancer	0.00322	0.00831	CbGbCtD
Selegiline—ABCB1—Paclitaxel—breast cancer	0.00313	0.00806	CbGbCtD
Selegiline—ABCB1—Irinotecan—breast cancer	0.00309	0.00795	CbGbCtD
Selegiline—CYP2C9—Fluorouracil—breast cancer	0.00305	0.00787	CbGbCtD
Selegiline—ABCB1—Vinblastine—breast cancer	0.00274	0.00707	CbGbCtD
Selegiline—CYP3A4—Vinorelbine—breast cancer	0.00267	0.00688	CbGbCtD
Selegiline—CYP2D6—Vinblastine—breast cancer	0.00258	0.00666	CbGbCtD
Selegiline—CYP3A4—Tamoxifen—breast cancer	0.00241	0.00621	CbGbCtD
Selegiline—CYP3A4—Mitoxantrone—breast cancer	0.00235	0.00605	CbGbCtD
Selegiline—ABCB1—Docetaxel—breast cancer	0.00226	0.00583	CbGbCtD
Selegiline—CYP3A4—Paclitaxel—breast cancer	0.00187	0.00483	CbGbCtD
Selegiline—CYP3A4—Irinotecan—breast cancer	0.00185	0.00477	CbGbCtD
Selegiline—ABCB1—Doxorubicin—breast cancer	0.00169	0.00435	CbGbCtD
Selegiline—CYP3A4—Vinblastine—breast cancer	0.00164	0.00424	CbGbCtD
Selegiline—ABCB1—Methotrexate—breast cancer	0.00163	0.00421	CbGbCtD
Selegiline—CYP2D6—Doxorubicin—breast cancer	0.00159	0.00409	CbGbCtD
Selegiline—CYP3A4—Docetaxel—breast cancer	0.00135	0.00349	CbGbCtD
Selegiline—CYP3A4—Doxorubicin—breast cancer	0.00101	0.0026	CbGbCtD
Selegiline—MAOB—nipple—breast cancer	0.000376	0.0427	CbGeAlD
Selegiline—Pseudoephedrine—IL2—breast cancer	0.00036	0.23	CrCbGaD
Selegiline—CYP2C8—mammary gland—breast cancer	0.000346	0.0393	CbGeAlD
Selegiline—MAOA—nipple—breast cancer	0.000321	0.0364	CbGeAlD
Selegiline—MAOB—embryo—breast cancer	0.00031	0.0352	CbGeAlD
Selegiline—CYP2C9—mammary gland—breast cancer	0.000307	0.0349	CbGeAlD
Selegiline—Ephedrine—ACHE—breast cancer	0.000281	0.18	CrCbGaD
Selegiline—CYP2A6—adipose tissue—breast cancer	0.000277	0.0315	CbGeAlD
Selegiline—CYP1A2—nipple—breast cancer	0.000268	0.0304	CbGeAlD
Selegiline—MAOA—embryo—breast cancer	0.000265	0.0301	CbGeAlD
Selegiline—MAOB—endometrium—breast cancer	0.000227	0.0258	CbGeAlD
Selegiline—MAOB—uterus—breast cancer	0.000209	0.0238	CbGeAlD
Selegiline—MAOB—pituitary gland—breast cancer	0.000205	0.0233	CbGeAlD
Selegiline—MAOB—adipose tissue—breast cancer	0.000204	0.0232	CbGeAlD
Selegiline—MAOA—endometrium—breast cancer	0.000194	0.022	CbGeAlD
Selegiline—MAOB—female reproductive system—breast cancer	0.000188	0.0214	CbGeAlD
Selegiline—MAOB—adrenal gland—breast cancer	0.000183	0.0208	CbGeAlD
Selegiline—MAOA—uterus—breast cancer	0.000178	0.0203	CbGeAlD
Selegiline—MAOA—pituitary gland—breast cancer	0.000175	0.0199	CbGeAlD
Selegiline—MAOA—adipose tissue—breast cancer	0.000174	0.0198	CbGeAlD
Selegiline—CYP2C8—endometrium—breast cancer	0.000173	0.0196	CbGeAlD
Selegiline—MAOB—female gonad—breast cancer	0.000171	0.0194	CbGeAlD
Selegiline—Ephedrine—BCHE—breast cancer	0.000165	0.106	CrCbGaD
Selegiline—CYP2B6—skin of body—breast cancer	0.000164	0.0187	CbGeAlD
Selegiline—MAOA—female reproductive system—breast cancer	0.00016	0.0182	CbGeAlD
Selegiline—MAOB—endocrine gland—breast cancer	0.000159	0.0181	CbGeAlD
Selegiline—MAOA—adrenal gland—breast cancer	0.000156	0.0178	CbGeAlD
Selegiline—CYP2C8—pituitary gland—breast cancer	0.000156	0.0177	CbGeAlD
Selegiline—MAOA—female gonad—breast cancer	0.000146	0.0166	CbGeAlD
Selegiline—CYP2C8—female reproductive system—breast cancer	0.000143	0.0162	CbGeAlD
Selegiline—CYP2C19—endocrine gland—breast cancer	0.000139	0.0158	CbGeAlD
Selegiline—MAOA—endocrine gland—breast cancer	0.000136	0.0154	CbGeAlD
Selegiline—CYP2B6—female reproductive system—breast cancer	0.000128	0.0146	CbGeAlD
Selegiline—CYP2C9—female reproductive system—breast cancer	0.000127	0.0144	CbGeAlD
Selegiline—CYP2B6—adrenal gland—breast cancer	0.000125	0.0142	CbGeAlD
Selegiline—Pseudoephedrine—TNF—breast cancer	0.000122	0.0777	CrCbGaD
Selegiline—CYP2C8—endocrine gland—breast cancer	0.000121	0.0137	CbGeAlD
Selegiline—CYP2E1—female reproductive system—breast cancer	0.00012	0.0137	CbGeAlD
Selegiline—CYP2E1—adrenal gland—breast cancer	0.000117	0.0133	CbGeAlD
Selegiline—CYP1A2—endocrine gland—breast cancer	0.000113	0.0129	CbGeAlD
Selegiline—ABCB1—embryo—breast cancer	0.000113	0.0129	CbGeAlD
Selegiline—MAOB—lymph node—breast cancer	0.00011	0.0125	CbGeAlD
Selegiline—CYP2B6—endocrine gland—breast cancer	0.000109	0.0123	CbGeAlD
Selegiline—CYP2C9—endocrine gland—breast cancer	0.000107	0.0122	CbGeAlD
Selegiline—CYP2E1—endocrine gland—breast cancer	0.000102	0.0116	CbGeAlD
Selegiline—CYP3A4—female reproductive system—breast cancer	9.68e-05	0.011	CbGeAlD
Selegiline—CYP2D6—female reproductive system—breast cancer	9.53e-05	0.0108	CbGeAlD
Selegiline—Benzyl alcohol—CYP1A1—breast cancer	9.4e-05	0.0601	CrCbGaD
Selegiline—MAOA—lymph node—breast cancer	9.38e-05	0.0107	CbGeAlD
Selegiline—ABCB1—epithelium—breast cancer	9.23e-05	0.0105	CbGeAlD
Selegiline—CYP2D6—female gonad—breast cancer	8.67e-05	0.00985	CbGeAlD
Selegiline—ABCB1—endometrium—breast cancer	8.28e-05	0.0094	CbGeAlD
Selegiline—CYP3A4—endocrine gland—breast cancer	8.2e-05	0.00931	CbGeAlD
Selegiline—CYP2D6—endocrine gland—breast cancer	8.07e-05	0.00916	CbGeAlD
Selegiline—ABCB1—uterus—breast cancer	7.63e-05	0.00867	CbGeAlD
Selegiline—ABCB1—pituitary gland—breast cancer	7.49e-05	0.00851	CbGeAlD
Selegiline—ABCB1—adipose tissue—breast cancer	7.46e-05	0.00848	CbGeAlD
Selegiline—Phentermine—CYP2D6—breast cancer	7.26e-05	0.0464	CrCbGaD
Selegiline—Benzyl alcohol—CYP2D6—breast cancer	7e-05	0.0447	CrCbGaD
Selegiline—Dextroamphetamine—CYP2D6—breast cancer	6.92e-05	0.0442	CrCbGaD
Selegiline—Pseudoephedrine—CYP2D6—breast cancer	6.88e-05	0.0439	CrCbGaD
Selegiline—ABCB1—female reproductive system—breast cancer	6.86e-05	0.00779	CbGeAlD
Selegiline—ABCB1—adrenal gland—breast cancer	6.69e-05	0.0076	CbGeAlD
Selegiline—ABCB1—bone marrow—breast cancer	6.47e-05	0.00735	CbGeAlD
Selegiline—ABCB1—female gonad—breast cancer	6.24e-05	0.00709	CbGeAlD
Selegiline—Benzyl alcohol—CYP3A4—breast cancer	6e-05	0.0383	CrCbGaD
Selegiline—ABCB1—endocrine gland—breast cancer	5.8e-05	0.00659	CbGeAlD
Selegiline—Amphetamine—CYP2D6—breast cancer	5.58e-05	0.0356	CrCbGaD
Selegiline—Methamphetamine—CYP2D6—breast cancer	5.17e-05	0.033	CrCbGaD
Selegiline—Phenelzine—CYP3A4—breast cancer	5.08e-05	0.0324	CrCbGaD
Selegiline—Benzphetamine—CYP3A4—breast cancer	4.4e-05	0.0281	CrCbGaD
Selegiline—ABCB1—lymph node—breast cancer	4.01e-05	0.00456	CbGeAlD
Selegiline—Decreased appetite—Docetaxel—breast cancer	1.51e-05	0.000101	CcSEcCtD
Selegiline—Hypersensitivity—Paclitaxel—breast cancer	1.51e-05	0.000101	CcSEcCtD
Selegiline—Headache—Fluorouracil—breast cancer	1.5e-05	0.000101	CcSEcCtD
Selegiline—Urinary tract disorder—Doxorubicin—breast cancer	1.5e-05	0.000101	CcSEcCtD
Selegiline—Oedema peripheral—Doxorubicin—breast cancer	1.5e-05	0.000101	CcSEcCtD
Selegiline—Dysgeusia—Methotrexate—breast cancer	1.5e-05	0.000101	CcSEcCtD
Selegiline—Gastrointestinal disorder—Docetaxel—breast cancer	1.5e-05	0.0001	CcSEcCtD
Selegiline—Dyspnoea—Capecitabine—breast cancer	1.49e-05	0.0001	CcSEcCtD
Selegiline—Fatigue—Docetaxel—breast cancer	1.49e-05	0.0001	CcSEcCtD
Selegiline—Angiopathy—Epirubicin—breast cancer	1.49e-05	0.0001	CcSEcCtD
Selegiline—Urethral disorder—Doxorubicin—breast cancer	1.49e-05	0.0001	CcSEcCtD
Selegiline—Nausea—Irinotecan—breast cancer	1.49e-05	9.99e-05	CcSEcCtD
Selegiline—Nausea—Mitoxantrone—breast cancer	1.49e-05	9.99e-05	CcSEcCtD
Selegiline—Constipation—Docetaxel—breast cancer	1.48e-05	9.94e-05	CcSEcCtD
Selegiline—Pain—Docetaxel—breast cancer	1.48e-05	9.94e-05	CcSEcCtD
Selegiline—Back pain—Methotrexate—breast cancer	1.48e-05	9.93e-05	CcSEcCtD
Selegiline—Dyspepsia—Capecitabine—breast cancer	1.48e-05	9.91e-05	CcSEcCtD
Selegiline—Chills—Epirubicin—breast cancer	1.48e-05	9.9e-05	CcSEcCtD
Selegiline—Arrhythmia—Epirubicin—breast cancer	1.47e-05	9.86e-05	CcSEcCtD
Selegiline—Visual impairment—Doxorubicin—breast cancer	1.47e-05	9.84e-05	CcSEcCtD
Selegiline—Asthenia—Paclitaxel—breast cancer	1.47e-05	9.84e-05	CcSEcCtD
Selegiline—Decreased appetite—Capecitabine—breast cancer	1.46e-05	9.79e-05	CcSEcCtD
Selegiline—Alopecia—Epirubicin—breast cancer	1.45e-05	9.75e-05	CcSEcCtD
Selegiline—Nausea—Gemcitabine—breast cancer	1.45e-05	9.73e-05	CcSEcCtD
Selegiline—Gastrointestinal disorder—Capecitabine—breast cancer	1.45e-05	9.72e-05	CcSEcCtD
Selegiline—Fatigue—Capecitabine—breast cancer	1.45e-05	9.7e-05	CcSEcCtD
Selegiline—Pruritus—Paclitaxel—breast cancer	1.45e-05	9.7e-05	CcSEcCtD
Selegiline—Vision blurred—Methotrexate—breast cancer	1.44e-05	9.68e-05	CcSEcCtD
Selegiline—Mental disorder—Epirubicin—breast cancer	1.44e-05	9.67e-05	CcSEcCtD
Selegiline—Pain—Capecitabine—breast cancer	1.43e-05	9.63e-05	CcSEcCtD
Selegiline—Constipation—Capecitabine—breast cancer	1.43e-05	9.63e-05	CcSEcCtD
Selegiline—Erythema—Epirubicin—breast cancer	1.43e-05	9.61e-05	CcSEcCtD
Selegiline—Malnutrition—Epirubicin—breast cancer	1.43e-05	9.61e-05	CcSEcCtD
Selegiline—Feeling abnormal—Docetaxel—breast cancer	1.43e-05	9.58e-05	CcSEcCtD
Selegiline—Nausea—Fluorouracil—breast cancer	1.43e-05	9.57e-05	CcSEcCtD
Selegiline—Ill-defined disorder—Methotrexate—breast cancer	1.42e-05	9.53e-05	CcSEcCtD
Selegiline—Tinnitus—Doxorubicin—breast cancer	1.42e-05	9.52e-05	CcSEcCtD
Selegiline—Gastrointestinal pain—Docetaxel—breast cancer	1.42e-05	9.51e-05	CcSEcCtD
Selegiline—Anaemia—Methotrexate—breast cancer	1.41e-05	9.49e-05	CcSEcCtD
Selegiline—Flushing—Doxorubicin—breast cancer	1.41e-05	9.48e-05	CcSEcCtD
Selegiline—Flatulence—Epirubicin—breast cancer	1.41e-05	9.47e-05	CcSEcCtD
Selegiline—Tension—Epirubicin—breast cancer	1.4e-05	9.43e-05	CcSEcCtD
Selegiline—Dysgeusia—Epirubicin—breast cancer	1.4e-05	9.41e-05	CcSEcCtD
Selegiline—Diarrhoea—Paclitaxel—breast cancer	1.4e-05	9.39e-05	CcSEcCtD
Selegiline—Nervousness—Epirubicin—breast cancer	1.39e-05	9.33e-05	CcSEcCtD
Selegiline—Back pain—Epirubicin—breast cancer	1.38e-05	9.29e-05	CcSEcCtD
Selegiline—Feeling abnormal—Capecitabine—breast cancer	1.38e-05	9.28e-05	CcSEcCtD
Selegiline—Angiopathy—Doxorubicin—breast cancer	1.38e-05	9.27e-05	CcSEcCtD
Selegiline—Malaise—Methotrexate—breast cancer	1.38e-05	9.26e-05	CcSEcCtD
Selegiline—Muscle spasms—Epirubicin—breast cancer	1.38e-05	9.24e-05	CcSEcCtD
Selegiline—Vertigo—Methotrexate—breast cancer	1.37e-05	9.22e-05	CcSEcCtD
Selegiline—Gastrointestinal pain—Capecitabine—breast cancer	1.37e-05	9.2e-05	CcSEcCtD
Selegiline—Abdominal pain—Docetaxel—breast cancer	1.37e-05	9.19e-05	CcSEcCtD
Selegiline—Body temperature increased—Docetaxel—breast cancer	1.37e-05	9.19e-05	CcSEcCtD
Selegiline—Leukopenia—Methotrexate—breast cancer	1.37e-05	9.19e-05	CcSEcCtD
Selegiline—Chills—Doxorubicin—breast cancer	1.36e-05	9.16e-05	CcSEcCtD
Selegiline—Arrhythmia—Doxorubicin—breast cancer	1.36e-05	9.12e-05	CcSEcCtD
Selegiline—Dizziness—Paclitaxel—breast cancer	1.35e-05	9.07e-05	CcSEcCtD
Selegiline—Vision blurred—Epirubicin—breast cancer	1.35e-05	9.06e-05	CcSEcCtD
Selegiline—Alopecia—Doxorubicin—breast cancer	1.34e-05	9.02e-05	CcSEcCtD
Selegiline—Cough—Methotrexate—breast cancer	1.33e-05	8.96e-05	CcSEcCtD
Selegiline—Mental disorder—Doxorubicin—breast cancer	1.33e-05	8.95e-05	CcSEcCtD
Selegiline—Urticaria—Capecitabine—breast cancer	1.33e-05	8.94e-05	CcSEcCtD
Selegiline—Ill-defined disorder—Epirubicin—breast cancer	1.33e-05	8.92e-05	CcSEcCtD
Selegiline—Abdominal pain—Capecitabine—breast cancer	1.33e-05	8.9e-05	CcSEcCtD
Selegiline—Body temperature increased—Capecitabine—breast cancer	1.33e-05	8.9e-05	CcSEcCtD
Selegiline—Convulsion—Methotrexate—breast cancer	1.33e-05	8.9e-05	CcSEcCtD
Selegiline—Erythema—Doxorubicin—breast cancer	1.32e-05	8.89e-05	CcSEcCtD
Selegiline—Malnutrition—Doxorubicin—breast cancer	1.32e-05	8.89e-05	CcSEcCtD
Selegiline—Anaemia—Epirubicin—breast cancer	1.32e-05	8.88e-05	CcSEcCtD
Selegiline—Agitation—Epirubicin—breast cancer	1.32e-05	8.83e-05	CcSEcCtD
Selegiline—Flatulence—Doxorubicin—breast cancer	1.3e-05	8.76e-05	CcSEcCtD
Selegiline—Chest pain—Methotrexate—breast cancer	1.3e-05	8.74e-05	CcSEcCtD
Selegiline—Arthralgia—Methotrexate—breast cancer	1.3e-05	8.74e-05	CcSEcCtD
Selegiline—Myalgia—Methotrexate—breast cancer	1.3e-05	8.74e-05	CcSEcCtD
Selegiline—Tension—Doxorubicin—breast cancer	1.3e-05	8.72e-05	CcSEcCtD
Selegiline—Vomiting—Paclitaxel—breast cancer	1.3e-05	8.72e-05	CcSEcCtD
Selegiline—Dysgeusia—Doxorubicin—breast cancer	1.3e-05	8.71e-05	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.29e-05	8.68e-05	CcSEcCtD
Selegiline—Malaise—Epirubicin—breast cancer	1.29e-05	8.66e-05	CcSEcCtD
Selegiline—Rash—Paclitaxel—breast cancer	1.29e-05	8.65e-05	CcSEcCtD
Selegiline—Dermatitis—Paclitaxel—breast cancer	1.29e-05	8.64e-05	CcSEcCtD
Selegiline—Discomfort—Methotrexate—breast cancer	1.29e-05	8.64e-05	CcSEcCtD
Selegiline—Nervousness—Doxorubicin—breast cancer	1.29e-05	8.64e-05	CcSEcCtD
Selegiline—Vertigo—Epirubicin—breast cancer	1.29e-05	8.63e-05	CcSEcCtD
Selegiline—Syncope—Epirubicin—breast cancer	1.28e-05	8.62e-05	CcSEcCtD
Selegiline—Leukopenia—Epirubicin—breast cancer	1.28e-05	8.6e-05	CcSEcCtD
Selegiline—Back pain—Doxorubicin—breast cancer	1.28e-05	8.6e-05	CcSEcCtD
Selegiline—Headache—Paclitaxel—breast cancer	1.28e-05	8.59e-05	CcSEcCtD
Selegiline—Hypersensitivity—Docetaxel—breast cancer	1.28e-05	8.57e-05	CcSEcCtD
Selegiline—Muscle spasms—Doxorubicin—breast cancer	1.27e-05	8.55e-05	CcSEcCtD
Selegiline—Palpitations—Epirubicin—breast cancer	1.26e-05	8.49e-05	CcSEcCtD
Selegiline—Confusional state—Methotrexate—breast cancer	1.26e-05	8.45e-05	CcSEcCtD
Selegiline—Loss of consciousness—Epirubicin—breast cancer	1.26e-05	8.45e-05	CcSEcCtD
Selegiline—Cough—Epirubicin—breast cancer	1.25e-05	8.38e-05	CcSEcCtD
Selegiline—Vision blurred—Doxorubicin—breast cancer	1.25e-05	8.38e-05	CcSEcCtD
Selegiline—Asthenia—Docetaxel—breast cancer	1.24e-05	8.34e-05	CcSEcCtD
Selegiline—Convulsion—Epirubicin—breast cancer	1.24e-05	8.33e-05	CcSEcCtD
Selegiline—Infection—Methotrexate—breast cancer	1.24e-05	8.32e-05	CcSEcCtD
Selegiline—Hypertension—Epirubicin—breast cancer	1.24e-05	8.3e-05	CcSEcCtD
Selegiline—Hypersensitivity—Capecitabine—breast cancer	1.24e-05	8.29e-05	CcSEcCtD
Selegiline—Ill-defined disorder—Doxorubicin—breast cancer	1.23e-05	8.25e-05	CcSEcCtD
Selegiline—Pruritus—Docetaxel—breast cancer	1.23e-05	8.23e-05	CcSEcCtD
Selegiline—Nervous system disorder—Methotrexate—breast cancer	1.22e-05	8.22e-05	CcSEcCtD
Selegiline—Anaemia—Doxorubicin—breast cancer	1.22e-05	8.22e-05	CcSEcCtD
Selegiline—Thrombocytopenia—Methotrexate—breast cancer	1.22e-05	8.2e-05	CcSEcCtD
Selegiline—Arthralgia—Epirubicin—breast cancer	1.22e-05	8.18e-05	CcSEcCtD
Selegiline—Myalgia—Epirubicin—breast cancer	1.22e-05	8.18e-05	CcSEcCtD
Selegiline—Chest pain—Epirubicin—breast cancer	1.22e-05	8.18e-05	CcSEcCtD
Selegiline—Agitation—Doxorubicin—breast cancer	1.22e-05	8.17e-05	CcSEcCtD
Selegiline—Anxiety—Epirubicin—breast cancer	1.21e-05	8.15e-05	CcSEcCtD
Selegiline—Nausea—Paclitaxel—breast cancer	1.21e-05	8.15e-05	CcSEcCtD
Selegiline—Skin disorder—Methotrexate—breast cancer	1.21e-05	8.14e-05	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.21e-05	8.12e-05	CcSEcCtD
Selegiline—Hyperhidrosis—Methotrexate—breast cancer	1.21e-05	8.1e-05	CcSEcCtD
Selegiline—Discomfort—Epirubicin—breast cancer	1.2e-05	8.08e-05	CcSEcCtD
Selegiline—Asthenia—Capecitabine—breast cancer	1.2e-05	8.08e-05	CcSEcCtD
Selegiline—Malaise—Doxorubicin—breast cancer	1.19e-05	8.02e-05	CcSEcCtD
Selegiline—Dry mouth—Epirubicin—breast cancer	1.19e-05	8e-05	CcSEcCtD
Selegiline—Vertigo—Doxorubicin—breast cancer	1.19e-05	7.99e-05	CcSEcCtD
Selegiline—Anorexia—Methotrexate—breast cancer	1.19e-05	7.99e-05	CcSEcCtD
Selegiline—Syncope—Doxorubicin—breast cancer	1.19e-05	7.97e-05	CcSEcCtD
Selegiline—Pruritus—Capecitabine—breast cancer	1.19e-05	7.96e-05	CcSEcCtD
Selegiline—Leukopenia—Doxorubicin—breast cancer	1.19e-05	7.96e-05	CcSEcCtD
Selegiline—Diarrhoea—Docetaxel—breast cancer	1.18e-05	7.95e-05	CcSEcCtD
Selegiline—Confusional state—Epirubicin—breast cancer	1.18e-05	7.91e-05	CcSEcCtD
Selegiline—Palpitations—Doxorubicin—breast cancer	1.17e-05	7.86e-05	CcSEcCtD
Selegiline—Oedema—Epirubicin—breast cancer	1.17e-05	7.84e-05	CcSEcCtD
Selegiline—Hypotension—Methotrexate—breast cancer	1.17e-05	7.83e-05	CcSEcCtD
Selegiline—Loss of consciousness—Doxorubicin—breast cancer	1.16e-05	7.81e-05	CcSEcCtD
Selegiline—Infection—Epirubicin—breast cancer	1.16e-05	7.79e-05	CcSEcCtD
Selegiline—Cough—Doxorubicin—breast cancer	1.16e-05	7.76e-05	CcSEcCtD
Selegiline—Shock—Epirubicin—breast cancer	1.15e-05	7.72e-05	CcSEcCtD
Selegiline—Convulsion—Doxorubicin—breast cancer	1.15e-05	7.7e-05	CcSEcCtD
Selegiline—Diarrhoea—Capecitabine—breast cancer	1.15e-05	7.7e-05	CcSEcCtD
Selegiline—Nervous system disorder—Epirubicin—breast cancer	1.15e-05	7.69e-05	CcSEcCtD
Selegiline—Dizziness—Docetaxel—breast cancer	1.15e-05	7.69e-05	CcSEcCtD
Selegiline—Thrombocytopenia—Epirubicin—breast cancer	1.14e-05	7.68e-05	CcSEcCtD
Selegiline—Hypertension—Doxorubicin—breast cancer	1.14e-05	7.68e-05	CcSEcCtD
Selegiline—Tachycardia—Epirubicin—breast cancer	1.14e-05	7.65e-05	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Methotrexate—breast cancer	1.14e-05	7.63e-05	CcSEcCtD
Selegiline—Skin disorder—Epirubicin—breast cancer	1.13e-05	7.62e-05	CcSEcCtD
Selegiline—Hyperhidrosis—Epirubicin—breast cancer	1.13e-05	7.58e-05	CcSEcCtD
Selegiline—Insomnia—Methotrexate—breast cancer	1.13e-05	7.58e-05	CcSEcCtD
Selegiline—Arthralgia—Doxorubicin—breast cancer	1.13e-05	7.57e-05	CcSEcCtD
Selegiline—Myalgia—Doxorubicin—breast cancer	1.13e-05	7.57e-05	CcSEcCtD
Selegiline—Chest pain—Doxorubicin—breast cancer	1.13e-05	7.57e-05	CcSEcCtD
Selegiline—Anxiety—Doxorubicin—breast cancer	1.12e-05	7.54e-05	CcSEcCtD
Selegiline—Paraesthesia—Methotrexate—breast cancer	1.12e-05	7.52e-05	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.12e-05	7.52e-05	CcSEcCtD
Selegiline—Discomfort—Doxorubicin—breast cancer	1.11e-05	7.48e-05	CcSEcCtD
Selegiline—Anorexia—Epirubicin—breast cancer	1.11e-05	7.48e-05	CcSEcCtD
Selegiline—Dyspnoea—Methotrexate—breast cancer	1.11e-05	7.47e-05	CcSEcCtD
Selegiline—Somnolence—Methotrexate—breast cancer	1.11e-05	7.45e-05	CcSEcCtD
Selegiline—Dizziness—Capecitabine—breast cancer	1.11e-05	7.44e-05	CcSEcCtD
Selegiline—Dry mouth—Doxorubicin—breast cancer	1.1e-05	7.4e-05	CcSEcCtD
Selegiline—Vomiting—Docetaxel—breast cancer	1.1e-05	7.39e-05	CcSEcCtD
Selegiline—Dyspepsia—Methotrexate—breast cancer	1.1e-05	7.38e-05	CcSEcCtD
Selegiline—Rash—Docetaxel—breast cancer	1.09e-05	7.33e-05	CcSEcCtD
Selegiline—Hypotension—Epirubicin—breast cancer	1.09e-05	7.33e-05	CcSEcCtD
Selegiline—Dermatitis—Docetaxel—breast cancer	1.09e-05	7.32e-05	CcSEcCtD
Selegiline—Confusional state—Doxorubicin—breast cancer	1.09e-05	7.32e-05	CcSEcCtD
Selegiline—Decreased appetite—Methotrexate—breast cancer	1.09e-05	7.28e-05	CcSEcCtD
Selegiline—Headache—Docetaxel—breast cancer	1.08e-05	7.28e-05	CcSEcCtD
Selegiline—Oedema—Doxorubicin—breast cancer	1.08e-05	7.26e-05	CcSEcCtD
Selegiline—Gastrointestinal disorder—Methotrexate—breast cancer	1.08e-05	7.23e-05	CcSEcCtD
Selegiline—Fatigue—Methotrexate—breast cancer	1.08e-05	7.22e-05	CcSEcCtD
Selegiline—Infection—Doxorubicin—breast cancer	1.07e-05	7.21e-05	CcSEcCtD
Selegiline—Pain—Methotrexate—breast cancer	1.07e-05	7.17e-05	CcSEcCtD
Selegiline—Vomiting—Capecitabine—breast cancer	1.07e-05	7.16e-05	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Epirubicin—breast cancer	1.06e-05	7.14e-05	CcSEcCtD
Selegiline—Shock—Doxorubicin—breast cancer	1.06e-05	7.14e-05	CcSEcCtD
Selegiline—Nervous system disorder—Doxorubicin—breast cancer	1.06e-05	7.12e-05	CcSEcCtD
Selegiline—Thrombocytopenia—Doxorubicin—breast cancer	1.06e-05	7.1e-05	CcSEcCtD
Selegiline—Rash—Capecitabine—breast cancer	1.06e-05	7.1e-05	CcSEcCtD
Selegiline—Insomnia—Epirubicin—breast cancer	1.06e-05	7.09e-05	CcSEcCtD
Selegiline—Dermatitis—Capecitabine—breast cancer	1.06e-05	7.09e-05	CcSEcCtD
Selegiline—Tachycardia—Doxorubicin—breast cancer	1.05e-05	7.08e-05	CcSEcCtD
Selegiline—Headache—Capecitabine—breast cancer	1.05e-05	7.05e-05	CcSEcCtD
Selegiline—Skin disorder—Doxorubicin—breast cancer	1.05e-05	7.05e-05	CcSEcCtD
Selegiline—Paraesthesia—Epirubicin—breast cancer	1.05e-05	7.04e-05	CcSEcCtD
Selegiline—Hyperhidrosis—Doxorubicin—breast cancer	1.04e-05	7.01e-05	CcSEcCtD
Selegiline—Dyspnoea—Epirubicin—breast cancer	1.04e-05	6.99e-05	CcSEcCtD
Selegiline—Somnolence—Epirubicin—breast cancer	1.04e-05	6.97e-05	CcSEcCtD
Selegiline—Anorexia—Doxorubicin—breast cancer	1.03e-05	6.92e-05	CcSEcCtD
Selegiline—Nausea—Docetaxel—breast cancer	1.03e-05	6.91e-05	CcSEcCtD
Selegiline—Feeling abnormal—Methotrexate—breast cancer	1.03e-05	6.91e-05	CcSEcCtD
Selegiline—Dyspepsia—Epirubicin—breast cancer	1.03e-05	6.9e-05	CcSEcCtD
Selegiline—Gastrointestinal pain—Methotrexate—breast cancer	1.02e-05	6.85e-05	CcSEcCtD
Selegiline—Decreased appetite—Epirubicin—breast cancer	1.02e-05	6.82e-05	CcSEcCtD
Selegiline—Hypotension—Doxorubicin—breast cancer	1.01e-05	6.78e-05	CcSEcCtD
Selegiline—Gastrointestinal disorder—Epirubicin—breast cancer	1.01e-05	6.77e-05	CcSEcCtD
Selegiline—Fatigue—Epirubicin—breast cancer	1.01e-05	6.76e-05	CcSEcCtD
Selegiline—Constipation—Epirubicin—breast cancer	9.99e-06	6.71e-05	CcSEcCtD
Selegiline—Pain—Epirubicin—breast cancer	9.99e-06	6.71e-05	CcSEcCtD
Selegiline—Nausea—Capecitabine—breast cancer	9.96e-06	6.69e-05	CcSEcCtD
Selegiline—Urticaria—Methotrexate—breast cancer	9.92e-06	6.66e-05	CcSEcCtD
Selegiline—Body temperature increased—Methotrexate—breast cancer	9.87e-06	6.62e-05	CcSEcCtD
Selegiline—Abdominal pain—Methotrexate—breast cancer	9.87e-06	6.62e-05	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Doxorubicin—breast cancer	9.85e-06	6.61e-05	CcSEcCtD
Selegiline—Insomnia—Doxorubicin—breast cancer	9.78e-06	6.56e-05	CcSEcCtD
Selegiline—Paraesthesia—Doxorubicin—breast cancer	9.7e-06	6.52e-05	CcSEcCtD
Selegiline—Dyspnoea—Doxorubicin—breast cancer	9.64e-06	6.47e-05	CcSEcCtD
Selegiline—Feeling abnormal—Epirubicin—breast cancer	9.63e-06	6.46e-05	CcSEcCtD
Selegiline—Somnolence—Doxorubicin—breast cancer	9.61e-06	6.45e-05	CcSEcCtD
Selegiline—Gastrointestinal pain—Epirubicin—breast cancer	9.55e-06	6.41e-05	CcSEcCtD
Selegiline—Dyspepsia—Doxorubicin—breast cancer	9.51e-06	6.39e-05	CcSEcCtD
Selegiline—Decreased appetite—Doxorubicin—breast cancer	9.4e-06	6.31e-05	CcSEcCtD
Selegiline—Gastrointestinal disorder—Doxorubicin—breast cancer	9.33e-06	6.26e-05	CcSEcCtD
Selegiline—Fatigue—Doxorubicin—breast cancer	9.32e-06	6.26e-05	CcSEcCtD
Selegiline—Urticaria—Epirubicin—breast cancer	9.28e-06	6.23e-05	CcSEcCtD
Selegiline—Constipation—Doxorubicin—breast cancer	9.24e-06	6.2e-05	CcSEcCtD
Selegiline—Pain—Doxorubicin—breast cancer	9.24e-06	6.2e-05	CcSEcCtD
Selegiline—Body temperature increased—Epirubicin—breast cancer	9.23e-06	6.2e-05	CcSEcCtD
Selegiline—Abdominal pain—Epirubicin—breast cancer	9.23e-06	6.2e-05	CcSEcCtD
Selegiline—Hypersensitivity—Methotrexate—breast cancer	9.2e-06	6.17e-05	CcSEcCtD
Selegiline—Asthenia—Methotrexate—breast cancer	8.96e-06	6.01e-05	CcSEcCtD
Selegiline—Feeling abnormal—Doxorubicin—breast cancer	8.91e-06	5.98e-05	CcSEcCtD
Selegiline—Gastrointestinal pain—Doxorubicin—breast cancer	8.84e-06	5.93e-05	CcSEcCtD
Selegiline—Pruritus—Methotrexate—breast cancer	8.83e-06	5.93e-05	CcSEcCtD
Selegiline—Hypersensitivity—Epirubicin—breast cancer	8.61e-06	5.78e-05	CcSEcCtD
Selegiline—Urticaria—Doxorubicin—breast cancer	8.59e-06	5.76e-05	CcSEcCtD
Selegiline—Abdominal pain—Doxorubicin—breast cancer	8.54e-06	5.74e-05	CcSEcCtD
Selegiline—Body temperature increased—Doxorubicin—breast cancer	8.54e-06	5.74e-05	CcSEcCtD
Selegiline—Diarrhoea—Methotrexate—breast cancer	8.54e-06	5.73e-05	CcSEcCtD
Selegiline—Asthenia—Epirubicin—breast cancer	8.38e-06	5.63e-05	CcSEcCtD
Selegiline—Pruritus—Epirubicin—breast cancer	8.26e-06	5.55e-05	CcSEcCtD
Selegiline—Dizziness—Methotrexate—breast cancer	8.25e-06	5.54e-05	CcSEcCtD
Selegiline—Diarrhoea—Epirubicin—breast cancer	7.99e-06	5.37e-05	CcSEcCtD
Selegiline—Hypersensitivity—Doxorubicin—breast cancer	7.96e-06	5.35e-05	CcSEcCtD
Selegiline—Vomiting—Methotrexate—breast cancer	7.94e-06	5.33e-05	CcSEcCtD
Selegiline—Rash—Methotrexate—breast cancer	7.87e-06	5.28e-05	CcSEcCtD
Selegiline—Dermatitis—Methotrexate—breast cancer	7.86e-06	5.28e-05	CcSEcCtD
Selegiline—Headache—Methotrexate—breast cancer	7.82e-06	5.25e-05	CcSEcCtD
Selegiline—Asthenia—Doxorubicin—breast cancer	7.75e-06	5.21e-05	CcSEcCtD
Selegiline—Dizziness—Epirubicin—breast cancer	7.72e-06	5.19e-05	CcSEcCtD
Selegiline—Pruritus—Doxorubicin—breast cancer	7.65e-06	5.13e-05	CcSEcCtD
Selegiline—Vomiting—Epirubicin—breast cancer	7.43e-06	4.99e-05	CcSEcCtD
Selegiline—Nausea—Methotrexate—breast cancer	7.41e-06	4.98e-05	CcSEcCtD
Selegiline—Diarrhoea—Doxorubicin—breast cancer	7.39e-06	4.96e-05	CcSEcCtD
Selegiline—Rash—Epirubicin—breast cancer	7.36e-06	4.94e-05	CcSEcCtD
Selegiline—Dermatitis—Epirubicin—breast cancer	7.36e-06	4.94e-05	CcSEcCtD
Selegiline—Headache—Epirubicin—breast cancer	7.32e-06	4.91e-05	CcSEcCtD
Selegiline—Dizziness—Doxorubicin—breast cancer	7.15e-06	4.8e-05	CcSEcCtD
Selegiline—Nausea—Epirubicin—breast cancer	6.94e-06	4.66e-05	CcSEcCtD
Selegiline—Vomiting—Doxorubicin—breast cancer	6.87e-06	4.61e-05	CcSEcCtD
Selegiline—Rash—Doxorubicin—breast cancer	6.81e-06	4.58e-05	CcSEcCtD
Selegiline—Dermatitis—Doxorubicin—breast cancer	6.81e-06	4.57e-05	CcSEcCtD
Selegiline—Headache—Doxorubicin—breast cancer	6.77e-06	4.55e-05	CcSEcCtD
Selegiline—Nausea—Doxorubicin—breast cancer	6.42e-06	4.31e-05	CcSEcCtD
Selegiline—CYP1A2—Metabolism—PTGS1—breast cancer	2.23e-06	3.32e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ENO1—breast cancer	2.23e-06	3.32e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—MTHFR—breast cancer	2.23e-06	3.31e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.22e-06	3.3e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CYP1B1—breast cancer	2.22e-06	3.3e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—TYMS—breast cancer	2.21e-06	3.28e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—HSP90AA1—breast cancer	2.2e-06	3.26e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.2e-06	3.26e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYP2D6—breast cancer	2.19e-06	3.25e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—NCOR1—breast cancer	2.18e-06	3.24e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PLA2G4A—breast cancer	2.18e-06	3.24e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—GSTM1—breast cancer	2.18e-06	3.24e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—HSP90AA1—breast cancer	2.18e-06	3.24e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.15e-06	3.19e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—NCOA2—breast cancer	2.15e-06	3.19e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—NCOA1—breast cancer	2.14e-06	3.18e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—COMT—breast cancer	2.13e-06	3.16e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—GSTP1—breast cancer	2.12e-06	3.15e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—NCOA1—breast cancer	2.12e-06	3.15e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—STK11—breast cancer	2.11e-06	3.13e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CYP19A1—breast cancer	2.11e-06	3.13e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CAV1—breast cancer	2.1e-06	3.12e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—HMOX1—breast cancer	2.09e-06	3.1e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—GPX1—breast cancer	2.09e-06	3.1e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CYP19A1—breast cancer	2.09e-06	3.1e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—STK11—breast cancer	2.09e-06	3.1e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—ITPR1—breast cancer	2.09e-06	3.1e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CD—breast cancer	2.09e-06	3.1e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—FASN—breast cancer	2.08e-06	3.1e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—MED12—breast cancer	2.08e-06	3.09e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—DPYD—breast cancer	2.08e-06	3.09e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—COMT—breast cancer	2.08e-06	3.09e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—BCHE—breast cancer	2.08e-06	3.08e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—GSTP1—breast cancer	2.07e-06	3.07e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CYP1A1—breast cancer	2.07e-06	3.07e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—ALB—breast cancer	2.06e-06	3.06e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—CAV1—breast cancer	2.06e-06	3.06e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—ERCC2—breast cancer	2.05e-06	3.05e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—SLC5A5—breast cancer	2.05e-06	3.04e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ALDOA—breast cancer	2.05e-06	3.04e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—HMOX1—breast cancer	2.04e-06	3.03e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—ITPR1—breast cancer	2.04e-06	3.02e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PTEN—breast cancer	2.02e-06	3e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—ABCB1—breast cancer	2.01e-06	2.98e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—NCOA3—breast cancer	1.99e-06	2.95e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—NQO1—breast cancer	1.98e-06	2.94e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—SLC2A1—breast cancer	1.98e-06	2.94e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—SLC2A2—breast cancer	1.97e-06	2.93e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—TYMS—breast cancer	1.97e-06	2.93e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—NOS3—breast cancer	1.97e-06	2.92e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.96e-06	2.91e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—COMT—breast cancer	1.96e-06	2.91e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—GSTP1—breast cancer	1.95e-06	2.9e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—NCOR1—breast cancer	1.95e-06	2.89e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PLA2G4A—breast cancer	1.95e-06	2.89e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—GSTM1—breast cancer	1.95e-06	2.89e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—COMT—breast cancer	1.94e-06	2.88e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.94e-06	2.88e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CPT1A—breast cancer	1.93e-06	2.87e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—MTR—breast cancer	1.93e-06	2.87e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ABCG2—breast cancer	1.93e-06	2.87e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GSTP1—breast cancer	1.93e-06	2.87e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYP3A4—breast cancer	1.93e-06	2.87e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—MTHFR—breast cancer	1.93e-06	2.86e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—TYMS—breast cancer	1.92e-06	2.86e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—HMOX1—breast cancer	1.92e-06	2.86e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.92e-06	2.85e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—ITPR1—breast cancer	1.92e-06	2.85e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CG—breast cancer	1.91e-06	2.84e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—HMOX1—breast cancer	1.91e-06	2.83e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—ITPR1—breast cancer	1.9e-06	2.82e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PLA2G4A—breast cancer	1.9e-06	2.82e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—NCOR1—breast cancer	1.9e-06	2.82e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—GSTM1—breast cancer	1.9e-06	2.82e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYP1B1—breast cancer	1.9e-06	2.82e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—HPGDS—breast cancer	1.9e-06	2.82e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—HBA1—breast cancer	1.88e-06	2.8e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CG—breast cancer	1.87e-06	2.78e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—GPX1—breast cancer	1.87e-06	2.77e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—HSP90AA1—breast cancer	1.86e-06	2.76e-05	CbGpPWpGaD
Selegiline—MAOB—Metabolism—AKT1—breast cancer	1.86e-06	2.76e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CYP1A1—breast cancer	1.85e-06	2.74e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—ABCB1—breast cancer	1.85e-06	2.74e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ACHE—breast cancer	1.84e-06	2.73e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTT1—breast cancer	1.84e-06	2.73e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—ERCC2—breast cancer	1.83e-06	2.72e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—ABCB1—breast cancer	1.83e-06	2.72e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—GPX1—breast cancer	1.82e-06	2.7e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CB—breast cancer	1.82e-06	2.7e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—TYMS—breast cancer	1.81e-06	2.69e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—NCOA1—breast cancer	1.81e-06	2.69e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CYP1A1—breast cancer	1.8e-06	2.68e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PTGS2—breast cancer	1.8e-06	2.67e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—TYMS—breast cancer	1.8e-06	2.67e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PLA2G4A—breast cancer	1.79e-06	2.66e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—NCOR1—breast cancer	1.79e-06	2.66e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—GSTM1—breast cancer	1.79e-06	2.66e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—ERCC2—breast cancer	1.79e-06	2.65e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—STK11—breast cancer	1.79e-06	2.65e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYP19A1—breast cancer	1.79e-06	2.65e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CAV1—breast cancer	1.78e-06	2.64e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—NCOR1—breast cancer	1.78e-06	2.64e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GSTM1—breast cancer	1.78e-06	2.64e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PLA2G4A—breast cancer	1.78e-06	2.64e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYP17A1—breast cancer	1.74e-06	2.59e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ENO1—breast cancer	1.72e-06	2.56e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PTGS1—breast cancer	1.72e-06	2.56e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—MTHFR—breast cancer	1.72e-06	2.56e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—GPX1—breast cancer	1.72e-06	2.55e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GPX1—breast cancer	1.7e-06	2.53e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.7e-06	2.52e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CYP1A1—breast cancer	1.7e-06	2.52e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYP2D6—breast cancer	1.69e-06	2.51e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—ERCC2—breast cancer	1.68e-06	2.5e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CYP1A1—breast cancer	1.68e-06	2.5e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CD—breast cancer	1.68e-06	2.5e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—MTHFR—breast cancer	1.68e-06	2.5e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.68e-06	2.49e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—ERCC2—breast cancer	1.67e-06	2.48e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—ALB—breast cancer	1.66e-06	2.47e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—COMT—breast cancer	1.66e-06	2.46e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—NCOA2—breast cancer	1.66e-06	2.46e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GSTP1—breast cancer	1.65e-06	2.45e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CD—breast cancer	1.65e-06	2.45e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—HMOX1—breast cancer	1.63e-06	2.42e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—ALB—breast cancer	1.63e-06	2.42e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ITPR1—breast cancer	1.63e-06	2.41e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CG—breast cancer	1.62e-06	2.41e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—FASN—breast cancer	1.61e-06	2.39e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—BCHE—breast cancer	1.6e-06	2.38e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—NOS3—breast cancer	1.59e-06	2.36e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CAV1—breast cancer	1.59e-06	2.36e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—MTHFR—breast cancer	1.58e-06	2.35e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—SLC5A5—breast cancer	1.58e-06	2.35e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PTEN—breast cancer	1.57e-06	2.33e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—MTHFR—breast cancer	1.57e-06	2.33e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ABCB1—breast cancer	1.56e-06	2.32e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—NOS3—breast cancer	1.56e-06	2.31e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CAV1—breast cancer	1.55e-06	2.3e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—TYMS—breast cancer	1.54e-06	2.28e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—SLC2A1—breast cancer	1.53e-06	2.27e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—NQO1—breast cancer	1.53e-06	2.27e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.52e-06	2.25e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GSTM1—breast cancer	1.52e-06	2.25e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—NCOR1—breast cancer	1.52e-06	2.25e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.52e-06	2.25e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CB—breast cancer	1.47e-06	2.18e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYP1B1—breast cancer	1.47e-06	2.18e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CAV1—breast cancer	1.46e-06	2.17e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GPX1—breast cancer	1.45e-06	2.16e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PTGS2—breast cancer	1.45e-06	2.16e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CAV1—breast cancer	1.45e-06	2.15e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CG—breast cancer	1.45e-06	2.15e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYP1A1—breast cancer	1.44e-06	2.14e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.44e-06	2.13e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CB—breast cancer	1.44e-06	2.13e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PIK3CA—breast cancer	1.43e-06	2.12e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ERCC2—breast cancer	1.43e-06	2.12e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CD—breast cancer	1.42e-06	2.12e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PTGS2—breast cancer	1.42e-06	2.11e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CG—breast cancer	1.41e-06	2.1e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—ALB—breast cancer	1.41e-06	2.09e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—NCOA1—breast cancer	1.4e-06	2.08e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.38e-06	2.05e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—STK11—breast cancer	1.38e-06	2.05e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYP19A1—breast cancer	1.38e-06	2.05e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—NOS3—breast cancer	1.35e-06	2e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—MTHFR—breast cancer	1.34e-06	1.99e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CG—breast cancer	1.33e-06	1.98e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CG—breast cancer	1.32e-06	1.96e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—COMT—breast cancer	1.28e-06	1.9e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTP1—breast cancer	1.27e-06	1.89e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CD—breast cancer	1.27e-06	1.89e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PTEN—breast cancer	1.27e-06	1.88e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—HMOX1—breast cancer	1.26e-06	1.87e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—ALB—breast cancer	1.26e-06	1.86e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ITPR1—breast cancer	1.25e-06	1.86e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CB—breast cancer	1.24e-06	1.84e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PTEN—breast cancer	1.24e-06	1.84e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CD—breast cancer	1.24e-06	1.84e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CAV1—breast cancer	1.24e-06	1.84e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PTGS2—breast cancer	1.23e-06	1.83e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—ALB—breast cancer	1.23e-06	1.82e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ABCB1—breast cancer	1.21e-06	1.79e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—NOS3—breast cancer	1.2e-06	1.78e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—TYMS—breast cancer	1.19e-06	1.76e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.18e-06	1.76e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—NOS3—breast cancer	1.17e-06	1.74e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—NCOR1—breast cancer	1.17e-06	1.74e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.17e-06	1.74e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTM1—breast cancer	1.17e-06	1.74e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CD—breast cancer	1.17e-06	1.74e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—AKT1—breast cancer	1.17e-06	1.73e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CD—breast cancer	1.16e-06	1.72e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—ALB—breast cancer	1.15e-06	1.71e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—ALB—breast cancer	1.14e-06	1.7e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CG—breast cancer	1.13e-06	1.67e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GPX1—breast cancer	1.12e-06	1.67e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYP1A1—breast cancer	1.11e-06	1.65e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CB—breast cancer	1.11e-06	1.65e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CA—breast cancer	1.11e-06	1.65e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—NOS3—breast cancer	1.1e-06	1.64e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ERCC2—breast cancer	1.1e-06	1.64e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PTGS2—breast cancer	1.1e-06	1.63e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—NOS3—breast cancer	1.09e-06	1.63e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CB—breast cancer	1.08e-06	1.61e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PTEN—breast cancer	1.07e-06	1.59e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PTGS2—breast cancer	1.07e-06	1.59e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—MTHFR—breast cancer	1.04e-06	1.54e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CB—breast cancer	1.02e-06	1.51e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CB—breast cancer	1.01e-06	1.5e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PTGS2—breast cancer	1.01e-06	1.5e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PTGS2—breast cancer	1e-06	1.49e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CD—breast cancer	9.91e-07	1.47e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ALB—breast cancer	9.78e-07	1.45e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PTEN—breast cancer	9.58e-07	1.42e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CAV1—breast cancer	9.55e-07	1.42e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—NOS3—breast cancer	9.36e-07	1.39e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PTEN—breast cancer	9.35e-07	1.39e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—AKT1—breast cancer	9.05e-07	1.34e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CA—breast cancer	8.94e-07	1.33e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PTEN—breast cancer	8.81e-07	1.31e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CA—breast cancer	8.76e-07	1.3e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PTEN—breast cancer	8.73e-07	1.3e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CG—breast cancer	8.7e-07	1.29e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CB—breast cancer	8.64e-07	1.28e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PTGS2—breast cancer	8.56e-07	1.27e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CD—breast cancer	7.65e-07	1.14e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CA—breast cancer	7.57e-07	1.12e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ALB—breast cancer	7.55e-07	1.12e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PTEN—breast cancer	7.46e-07	1.11e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—AKT1—breast cancer	7.3e-07	1.08e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—NOS3—breast cancer	7.22e-07	1.07e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—AKT1—breast cancer	7.15e-07	1.06e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CA—breast cancer	6.76e-07	1e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CB—breast cancer	6.67e-07	9.9e-06	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PTGS2—breast cancer	6.6e-07	9.81e-06	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CA—breast cancer	6.59e-07	9.79e-06	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CA—breast cancer	6.21e-07	9.23e-06	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—AKT1—breast cancer	6.18e-07	9.18e-06	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CA—breast cancer	6.16e-07	9.15e-06	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PTEN—breast cancer	5.76e-07	8.55e-06	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—AKT1—breast cancer	5.52e-07	8.2e-06	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—AKT1—breast cancer	5.39e-07	8e-06	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CA—breast cancer	5.26e-07	7.82e-06	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—AKT1—breast cancer	5.08e-07	7.54e-06	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—AKT1—breast cancer	5.03e-07	7.47e-06	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—AKT1—breast cancer	4.3e-07	6.39e-06	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CA—breast cancer	4.06e-07	6.03e-06	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—AKT1—breast cancer	3.32e-07	4.93e-06	CbGpPWpGaD
